We’re developing a cheap, fast and accurate point-of-care test for babies born to HIV-infected mothers. Help us take it forward into clinical trials.
Alcohol and other drugs are a major issue in Australia and Burnet has an established reputation in working to alleviate harms associated with their use.
Blood-borne viruses cause major health problems in low and middle income countries, yet the most vulnerable people often can’t access effective treatments.
Understanding the role of key signalling molecules that are critical for the normal development and function of T and B lymphocytes.
Adolescence as a key developmental stage within the life-course, where investments bring a triple dividend of benefits – now, into future adult life, and for the next generation of children.
There is an unmet need for new and/or improved tests for many diseases that predominantly affect disadvantaged populations.
Improving health outcomes for at-risk mothers and newborn babies.
A team of researchers and project staff aiming to define the major causes of poor maternal, newborn and infant care in PNG.
Conducts innovative research aimed at understanding the transmission and prevention of HIV.
Discovering new ways to treat disease by manipulating the immune system.
Developing interventions to decay the HIV reservoir, improve immune function, and prevent early onset of age-associated conditions in people living with HIV.
Develop prognostic tools and adjunctive therapies to predict and improve health outcomes for HIV patients.
Researching the causes of variability in the growth of influenza B viruses in eggs and developing methods to increase yields of vaccine antigens.
Undertakes research to build the evidence base for policy and practice to improve outcomes for prisoners and ex-prisoners.
Understanding malaria dynamics in populations is key to implementing effective public health control measures.
Improving surveillance, diagnostics, clinical treatment, prevention and disease control for malaria, TB and other tropical diseases.
Research focussed on immunity, vaccines, new treatments and clinical studies of malaria.
Malaria is a devastating parasitic disease that is becoming resistant to current medicines so new treatments need to be developed for future use.
Women and children continue to die and suffer significant illness from preventable causes.
Using mathematical, epidemiological and economic models to inform better public health and resource allocation decisions.
Discovery of new drug targets for antiretroviral therapy and prevention.
Researching neurological disorders and opportunistic infections of the central nervous system (CNS) in HIV infected individuals.
This group manages HIV, Viral Hepatitis and STIs surveillance systems and conducts evaluations of projects and programs.
Supporting national tuberculosis programs in the Asia-Pacific region to address drug-resistant tuberculosis.
Accelerating towards elimination of vector-borne diseases such as malaria and lymphatic filariasis requires new approaches to diagnosis, surveillance and intervention.
Examining how HIV and hepatitis C virus attach to and enter cells.
Improving the understanding of hepatitis C and its transmission, and the management and care of people already infected with these viruses.
Examines the epidemiology and consequences of risk behaviours among young people.
To achieve better health for vulnerable communities in Australia and internationally by accelerating the translation of research, discovery and evidence into sustainable health solutions.
85 Commercial Road, Melbourne
VIC, 3004, Australia
Receive updates and IMPACT magazine.
Copyright © 2019 Burnet Institute. ABN: 49 007 349 984
This website was developed with the generous support of a donor.
Burnet Institute (Australia) is located on the traditional land of the Boon Wurrung and Wurundjeri people and we offer our respects to the elders past and present.
We recognise and respect the cultural heritage of this land.